Corbus Pharmaceuticals Holdings, Inc.
CRBP
$10.09
$0.010.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -98.38% | -35.29% | -115.69% | -69.35% | -76.67% |
| Total Depreciation and Amortization | -3.77% | -39.51% | -63.43% | -67.11% | -64.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 79.05% | 12.06% | -25.30% | -3.78% | 212.68% |
| Change in Net Operating Assets | 2,990.16% | -330.50% | 250.39% | 403.90% | -75.00% |
| Cash from Operations | -78.48% | -55.72% | -45.50% | -11.53% | -85.61% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.95% | 23.94% | -754.50% | 227.81% | 207.93% |
| Cash from Investing | 2.91% | 23.90% | -754.58% | 227.81% | 207.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -92.07% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 573,753.85% | -88.62% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -300.26% | -283.08% | 167.82% | 262.77% | -88.06% |